Vicore Pharma Holding AB(SE:VICO)
kr 10.28-0.04 (-0.39%)
SE:VICO
Vicore Pharma Holding AB financials statements
kr 10.28
At close:-0.04 (-0.39%)
Want to see SE:VICO full AI Analyst Report?
Vicore Pharma Holding AB (VICO) Ratios
4 Followers
Vicore Pharma Holding AB Ratios
SE:VICO's free cash flow for Q3 2026 was kr-137.47M. For the 2026 fiscal year, SE:VICO's free cash flow was increased by kr0.00 and operating cash flow was kr-137.47M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.31 | 16.50 | 12.10 | 5.81 | 5.75 |
| Quick Ratio | 10.31 | 16.50 | 12.10 | 5.81 | 5.75 |
| Cash Ratio | 4.89 | 15.86 | 8.15 | 5.53 | 4.48 |
| Solvency Ratio | -3.85 | -2.26 | -7.24 | -5.82 | -4.32 |
| Operating Cash Flow Ratio | -3.17 | -2.26 | -6.09 | -6.46 | -4.03 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 1.10B | kr 1.13B | kr 453.15M | kr 220.87M | kr 310.08M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.11 | 1.07 | 1.09 | 1.17 | 1.18 |
| Debt Service Coverage Ratio | -9.48 | -20798.00 | -885.70 | -35727.13 | -26324.36 |
| Interest Coverage Ratio | -9.03 | -24273.63 | -898.06 | -36340.63 | -26801.64 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.21 | 6.94 | 1.05 | 0.90 | 1.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -12507.57% | -154.45% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -12507.57% | -152.40% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -11905.82% | -177.59% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -12509.14% | -154.45% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -12509.14% | -154.22% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -12509.14% | -154.22% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 99.85% | 99.88% | 99.87% | 99.91% |
| EBT Per EBIT | 105.07% | 86.97% | 96.83% | 99.34% | 100.65% |
| Return on Assets (ROA) | -39.15% | -14.02% | -62.46% | -85.33% | -65.71% |
| Return on Equity (ROE) | -43.59% | -14.93% | -68.28% | -99.77% | -77.35% |
| Return on Capital Employed (ROCE) | -41.26% | -17.18% | -70.37% | -99.70% | -76.49% |
| Return on Invested Capital (ROIC) | -41.20% | -17.16% | -70.28% | -99.55% | -76.42% |
| Return on Tangible Assets | -39.15% | -14.02% | -62.74% | -106.86% | -77.26% |
| Earnings Yield | -17.61% | -8.86% | -23.34% | -22.93% | -31.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.28 | 5.54 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.19 | 0.15 | 0.15 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.09 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 1319.91 | 65.94 | -1911.53 | -2374.22 | -2433.06 |
| Days of Sales Outstanding | 1319.91 | 65.94 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 1911.53 | 2374.22 | 2433.06 |
| Operating Cycle | 1319.91 | 65.94 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.56 | -0.73 | -2.58 | -4.15 | -3.81 |
| Free Cash Flow Per Share | -1.57 | -0.73 | -4.65 | -4.19 | -3.81 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | -1.25 | -99.97 | 0.00 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | -1.25 | -99.97 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | -4614.14 | -828.66 |
| Operating Cash Flow to Sales Ratio | -98.10 | -1.51 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -13.86% | -8.66% | -33.67% | -24.08% | -28.11% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.68 | -11.27 | -4.29 | -4.36 | -3.18 |
| Price-to-Sales (P/S) Ratio | 710.16 | 17.41 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.47 | 1.69 | 2.93 | 4.35 | 2.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.21 | -11.54 | -2.97 | -4.15 | -3.56 |
| Price-to-Operating Cash Flow Ratio | -7.24 | -11.54 | -5.34 | -4.19 | -3.56 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | 0.15 | 0.22 | 0.71 | -0.06 |
| Enterprise Value Multiple | -4.47 | -4.49 | -3.15 | -3.50 | -2.24 |
| Enterprise Value | 2.13B | 747.92M | 998.89M | 1.00B | 649.57M |
| EV to EBITDA | -4.47 | -4.49 | -3.15 | -3.50 | -2.24 |
| EV to Sales | 558.69 | 6.84 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -5.68 | -4.53 | -2.23 | -3.31 | -2.45 |
| EV to Operating Cash Flow | -5.70 | -4.53 | -4.00 | -3.34 | -2.45 |
| Tangible Book Value Per Share | 4.57 | 5.01 | 4.69 | 3.06 | 4.53 |
| Shareholders’ Equity Per Share | 4.57 | 5.01 | 4.72 | 4.00 | 5.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.02 | 0.49 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.99 | -0.75 | -3.22 | -3.99 | -4.25 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.97 | 1.00 | 1.01 |
| Research & Development to Revenue | 102.27 | 2.28 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 17.79 | 0.46 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.78 | 0.85 | 0.80 | 1.03 | 0.90 |
Currency in SEK

